Human mast cells stimulate activated T cells: implications for multiple sclerosis

Area of Science:

• Neuroimmunology
• Pathophysiology of Multiple Sclerosis

Background:

• Multiple sclerosis (MS) is an autoimmune demyelinating disease primarily involving Th1 and Th17 cells crossing the blood-brain barrier.
• Emerging evidence implicates Th2 cells and mast cells, typically linked to allergic responses, in MS pathogenesis.
• Brain mast cells, situated perivascularly, release mediators that compromise the blood-brain barrier, potentially preceding clinical MS signs.

Purpose of the Study:

• To investigate the role of brain mast cells and their interaction with T cells in the context of multiple sclerosis.
• To explore the potential of targeting mast cell activation and T cell responses as a therapeutic strategy for MS.

Main Methods:

• The study reviews evidence on mast cell activation in the brain by neural factors like substance P and myelin basic protein.
• It examines how mast cells stimulate T cells at the blood-brain barrier and in response to specific antigens.
• The effect of luteolin, a flavone, in blocking mast cell and T cell activation was assessed in the context of experimental autoimmune encephalitis (EAE).

Main Results:

• Brain mast cells are activated by stress-related neural factors, releasing inflammatory mediators that disrupt the blood-brain barrier.
• Mast cells can directly stimulate T cells, contributing to the inflammatory process in MS.
• Pretreatment with luteolin demonstrated a blockade of mast cell and T cell activation, reducing experimental autoimmune encephalitis severity.

Conclusions:

• Interactions between brain mast cells and T cells represent a significant pathway in multiple sclerosis pathogenesis.
• These mast cell-T cell interactions present a novel and promising therapeutic target for managing multiple sclerosis.